Tobacco Use Intervention Among Radiation Oncology Patients
1 other identifier
interventional
26
1 country
1
Brief Summary
Tobacco prevention and intervention strategies in the general population are ongoing and evolving. However, strategies to help cancer patients overcome tobacco dependence have been limited. Radiation oncology patients who continue to smoke despite their cancer diagnosis have a lower quality of life (QOL), increased frequency and severity of side effects during their cancer treatment, higher risks of developing a smoking-related primary cancer, and may have a poorer survival rate than their non-smoking counterparts. These are all compelling reasons to be more pro-active in helping cancer patients stop smoking. The overall objective of this project is to adapt a model of an effective tobacco use intervention that can be delivered by any trained radiation oncologist and their staff.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jan 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2007
CompletedStudy Start
First participant enrolled
January 1, 2008
CompletedFirst Posted
Study publicly available on registry
January 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedMay 2, 2012
May 1, 2012
1.8 years
December 21, 2007
May 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary aim is to pilot test the intervention in radiation oncology patients (N=30). The primary dependent measure is self-reported 7-day point prevalence tobacco abstinence confirmed with expired air carbon monoxide.
6 months
Secondary Outcomes (1)
We will be collecting data on QOL and psychosocial measures. This data will be reported descriptively and will be collected on our future study with appropriate statistical analyses.
6 months
Interventions
A novel approach to providing an intervention for tobacco users who are receiving radiation therapy is to provide an individual tobacco use intervention that utilizes concepts of motivational interviewing strategies to facilitate self-exploration of the reasons for continued smoking and a treatment plan that is comprehensive and builds self-efficacy, provides one-on-one counseling, and includes tobacco treatment pharmacotherapies. The pharmacotherapies will be tailored to the patients needs. One could utilize varenicline, bupropion, and/or nicotine replacement therapies.
Eligibility Criteria
You may qualify if:
- at least 18 years of age;
- current cigarette smoker (smoked any cigarettes within the previous 7 days prior to their first visit) or recent ex-smoker (last cigarette smoked was \>7 but ≤ 30 days);
- planning to undergo radiation therapy (RT) that is to be delivered by the members of the Department of Radiation Oncology in Rochester, MN;
- be receiving a minimum of 5 weeks of RT and/or be willing to return for all 5 sessions.
You may not qualify if:
- patient is currently (in previous 30 days) using other formal behavioral tobacco cessation program \[i.e., behavioral therapy (Nicotine Dependence Consultation and treatment) or telephone quitline\];
- daily use of tobacco products other than cigarettes;
- hospitalized patients;
- Karnofsky Performance Status (KPS) score of \< 60 (KPS = 60 corresponds to a person who requires occasional assistance but is able to care for most of their own needs;
- presence of an unstable or untreated psychiatric disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yolanda I Garces, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 21, 2007
First Posted
January 7, 2008
Study Start
January 1, 2008
Primary Completion
November 1, 2009
Study Completion
December 1, 2009
Last Updated
May 2, 2012
Record last verified: 2012-05